BioSpace News Archive

Contribution includes upfront donation and matching funds to address increasing food insecurity needs related to the coronavirus

New coronavirus test may be able to confirm COVID-19 in under one hour at the point of care

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies for solid tumors, today announced that it has closed a $45 million Series E financing. The round was led by Lyell Immunopharma and joined by a syndicate of new and prior investors. In addition to the financing, Eureka and Lyell have entered into a strategic collaboration to develop therapies against several undisclos

Artio Medical, a medical device company developing innovative products for peripheral vascular and neurovascular diseases, announced today the recent presentation of interim nonclinical study results at the ABC-WIN Seminar in Val d’Isere, France . Presented by Dr. Blaise Baxter , a neurovascular and peripheral interventional radiol

Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces it has begun enrolling patients in its Phase 1 clinical trial to address safety and efficacy of its novel stem cell technology, AmnioBoost, for the treatment of severe acute respiratory syndrome (SARS) related to COVID-19 infection. AmnioBoost is derived from amniotic fluid taken from non-related, healthy, living

Following initial public offering and private placement, Cortexyme is well capitalized and focused on high quality execution of the Phase 2/3 GAIN Trial

Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam ® Compact proton therapy system. The center, a collaboration between The University of Alabama at Birmingham (UAB) and Proton International, opened in January 2020 and is the first proton therapy c

The Inc. magazine revealed that DoctorLogic, creator of the Website Marketing Platform exclusively for healthcare providers, is No. 122 on its inaugural Inc.

Orexo AB, hosts a Capital Market Day in Stockholm, Sweden. On the day the company will present an overview of the company’s growth strategy, pharmaceutical pipeline and digital therapies.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that a new FDA policy released last night aimed at expediting the availability of COVID-19 diagnostics will allow the Company to aggressively expand its presence in the U.S. market..